321 related articles for article (PubMed ID: 36757683)
1. Barriers and facilitators to implementing medications for opioid use disorder and naloxone distribution in Veterans Affairs emergency departments.
Sasson C; Dieujuste N; Klocko R; Basrai Z; Celedon M; Hsiao J; Himstreet J; Hoffman J; Pfaff C; Malmstrom R; Smith J; Holstein A; Johnson-Koenke R
Acad Emerg Med; 2023 Apr; 30(4):289-298. PubMed ID: 36757683
[TBL] [Abstract][Full Text] [Related]
2. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
Kohan LR; Elmofty D; Pena I; Liao C
J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
[TBL] [Abstract][Full Text] [Related]
3. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.
Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162
[TBL] [Abstract][Full Text] [Related]
4. Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities.
Hagedorn H; Kenny M; Gordon AJ; Ackland PE; Noorbaloochi S; Yu W; Harris AHS
Addict Sci Clin Pract; 2018 Dec; 13(1):25. PubMed ID: 30545409
[TBL] [Abstract][Full Text] [Related]
5. Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings.
Winograd RP; Davis CS; Niculete M; Oliva E; Martielli RP
Subst Abus; 2017; 38(2):135-140. PubMed ID: 28486076
[TBL] [Abstract][Full Text] [Related]
6. Barriers and Facilitators to Implementation of Pharmacotherapy for Opioid Use Disorders in VHA Residential Treatment Programs.
Finlay AK; Wong JJ; Ellerbe LS; Rubinsky A; Gupta S; Bowe TR; Schmidt EM; Timko C; Burden JL; Harris AHS
J Stud Alcohol Drugs; 2018 Nov; 79(6):909-917. PubMed ID: 30573022
[TBL] [Abstract][Full Text] [Related]
7. Implementation of a pharmacist care manager model to expand availability of medications for opioid use disorder.
DeRonne BM; Wong KR; Schultz E; Jones E; Krebs EE
Am J Health Syst Pharm; 2021 Feb; 78(4):354-359. PubMed ID: 33326564
[TBL] [Abstract][Full Text] [Related]
8. Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings.
Speight C; Caiola C; Tyndall DE; Scott ES
J Am Assoc Nurse Pract; 2023 Feb; 35(2):112-121. PubMed ID: 36512806
[TBL] [Abstract][Full Text] [Related]
9. Naloxone provision to emergency department patients recognized as high-risk for opioid use disorder.
Lane BH; Lyons MS; Stolz U; Ancona RM; Ryan RJ; Freiermuth CE
Am J Emerg Med; 2021 Feb; 40():173-176. PubMed ID: 33243535
[TBL] [Abstract][Full Text] [Related]
10. Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps.
Wyse JJ; Gordon AJ; Dobscha SK; Morasco BJ; Tiffany E; Drexler K; Sandbrink F; Lovejoy TI
Subst Abus; 2018; 39(2):139-144. PubMed ID: 29595375
[TBL] [Abstract][Full Text] [Related]
11. Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment.
Bounthavong M; Suh K; Christopher MLD; Veenstra DL; Basu A; Devine EB
Res Social Adm Pharm; 2020 Aug; 16(8):1033-1040. PubMed ID: 31706950
[TBL] [Abstract][Full Text] [Related]
12. Provider Perceptions of Opioid Safety Measures in VHA Emergency Departments and Urgent Care Centers.
Dieujuste N; Johnson-Koenke R; Celedon M; Basrai Z; Christopher M; Smith J; Sasson C
Fed Pract; 2021 Sep; 38(9):412-419. PubMed ID: 34737538
[TBL] [Abstract][Full Text] [Related]
13. Barriers and Facilitators to Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine.
Hawk KF; D'Onofrio G; Chawarski MC; O'Connor PG; Cowan E; Lyons MS; Richardson L; Rothman RE; Whiteside LK; Owens PH; Martel SH; Coupet E; Pantalon M; Curry L; Fiellin DA; Edelman EJ
JAMA Netw Open; 2020 May; 3(5):e204561. PubMed ID: 32391893
[TBL] [Abstract][Full Text] [Related]
14. Assessment of a naloxone distribution plan in a veteran population who experienced an opioid-related overdose event.
Alexander M; Hooker J; Stratton M; Huh M; Houck K
J Am Pharm Assoc (2003); 2024; 64(3):101999. PubMed ID: 38151200
[TBL] [Abstract][Full Text] [Related]
15. A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department.
Wiercigroch D; Hoyeck P; Sheikh H; Hulme J
BMC Emerg Med; 2021 Apr; 21(1):48. PubMed ID: 33858328
[TBL] [Abstract][Full Text] [Related]
16. Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs.
Oliva EM; Nevedal A; Lewis ET; McCaa MD; Cochran MF; Konicki PE; Davis CS; Wilder C
Subst Abus; 2016; 37(1):118-26. PubMed ID: 26675643
[TBL] [Abstract][Full Text] [Related]
17. Opioid use and opioid use disorder in mono and dual-system users of veteran affairs medical centers.
Goulet J; Cheng Y; Becker W; Brandt C; Sandbrink F; Workman TE; Ma P; Libin A; Shara N; Spevak C; Kupersmith J; Zeng-Treitler Q
Front Public Health; 2023; 11():1148189. PubMed ID: 37124766
[TBL] [Abstract][Full Text] [Related]
18. A qualitative exploration of dentists' opioid prescribing decisions within U.S. veterans affairs facilities.
Sharp LK; Solanki P; Boyer T; Vivo A; Kale I; Hughes AM; Gibson G; Jurasic MM; Evans CT; Suda KJ
Pain; 2023 Apr; 164(4):749-757. PubMed ID: 35984367
[TBL] [Abstract][Full Text] [Related]
19. Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study.
Radomski TR; Bixler FR; Zickmund SL; Roman KM; Thorpe CT; Hale JA; Sileanu FE; Hausmann LRM; Thorpe JM; Suda KJ; Stroupe KT; Gordon AJ; Good CB; Fine MJ; Gellad WF
J Gen Intern Med; 2018 Aug; 33(8):1253-1259. PubMed ID: 29520747
[TBL] [Abstract][Full Text] [Related]
20. Barriers and facilitators for family physicians prescribing opioid agonist therapy in Saskatchewan.
Nguyen T; Bareham J; Halpape K
Can Fam Physician; 2024 Apr; 70(4):e52-e60. PubMed ID: 38626996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
